News
Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback